| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Technology Officer
1 company
Lingamneni Anila is an EVP, Chief Technology Officer at HAE. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $1.9M at current prices.
Our model assigns Lingamneni Anila a middling insider score of 62/100, based on 9 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +3.9%.
Lingamneni Anila's largest disclosed position is in HAE as EVP, Chief Technology Officer, worth about $1.9M. The recent filings there lean toward selling, a net 10,964 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 2,215 | $90.00 | $199,350.00 | -9.4% | -17.8% | -16.6% | |
| May 6, 2024 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 2,305 | $95.00 | $218,975.00 | -15.8% | -9.2% | -33.3% | |
| Sep 11, 2023 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 2,305 | $90.00 | $207,450.00 | -13.7% | -6.2% | -18.5% | |
| May 30, 2023 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 2,304 | $83.33 | $191,992.32 | -12.1% | +5.9% | +4.8% | |
| May 19, 2022 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 1,384 | $59.10 | $81,794.40 | -7.4% | +26.2% | +39.8% | |
| Apr 18, 2022 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 189 | $56.55 | $10,687.95 | -1.3% | +11.9% | +49.7% | |
| May 19, 2021 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 92 | $55.19 | $5,077.48 | -0.6% | +4.9% | +6.5% | |
| Apr 16, 2021 | HAE Haemonetics Corp | EVP, Chief Technology Officer | Sell | 170 | $119.44 | $20,304.80 | -4.7% | -48.5% | -51.5% |